Data on the epidemiology of heart failure in Sub-Saharan Africa

Nyaga, Ulrich Flore; Bigna, Jean Joël; Agbor, Valirie Ndip; Essouma, Mickael; Ntusi, Ntobeko; Noubiap, Jean Jacques

doi:10.1016/j.dib.2018.01.100

Cited by 31 publications

(33 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Loop diuretics are the commonest medication used for the treatment of HF in SSA (81.6, 95% CI: 72.7-89.1%) This is followed by angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (75%, 95% CI: 64.4-85.1%), aldosterone antagonists (51.5%, 95% CI: 32.4-70%), beta-blockers (31.4%, 95% CI: 22.6-40.9%) and digoxin (31.5%, 95% CI: 19.4-45%) [221,222].…”

Section: Drug Treatmentmentioning

confidence: 99%

“…Thirty-day mortality rate ranges from 14.7 to 35% [221,234]. The reported 60-and 180-days readmission or mortality is 15-57.8 and 21.9-57.9%, respectively.…”

Section: Short-and Medium-term Mortalitymentioning

confidence: 99%

“…Common predictors of readmission or mortality include presence of malignancy, severe lung disease, admission for blood pressure, heart rate, signs of congestion, renal function and ejection fraction. Others include anaemia, history of smoking and HIV co-infection [221,234].…”

Section: Short-and Medium-term Mortalitymentioning

confidence: 99%

See 2 more Smart Citations

Heart Failure in Sub-Saharan Africa

Adebiyi¹,

Sliwa‐Hähnle²

2019

Topics in Heart Failure Management

View full text Add to dashboard Cite

Sub-Saharan Africa (SSA) is currently experiencing multiple burden of disease as a result of demographic and epidemiologic transition. This is occasioned rapid urbanization, unhealthy diets rich in fats and salt, western lifestyle and sedentary living. Heart failure (HF) has become a global public health issue. It is associated with high morbidity and mortality, frequent hospitalization and high economic cost. In SSA, HF is a disease of young and middle-aged adults with the attendant high disability-adjusted life years. This is unlike to the clinical profile and pattern of HF in high-income countries of North America, Western Europe and Japan where HF is a disease of the elderly. In addition, while ischaemic heart disease is the commonest aetiologic risk factor for HF in high income countries, HF in SSA is essentially non-ischaemic in origin. Hypertensive heart failure, dilated cardiomyopathy, rheumatic heart disease, pericardial diseases and HIV associated cardiomyopathy are the common risk factors. The chapter reviews the contemporary information on HF in SSA in terms of socio-demographic features, clinical characteristics, aetiological risk factors, management, prognosis and economic burden.

show abstract

Section: Drug Treatmentmentioning

confidence: 99%

“…Thirty-day mortality rate ranges from 14.7 to 35% [221,234]. The reported 60-and 180-days readmission or mortality is 15-57.8 and 21.9-57.9%, respectively.…”

Section: Short-and Medium-term Mortalitymentioning

confidence: 99%

See 1 more Smart Citation

Heart Failure in Sub-Saharan Africa

Adebiyi¹,

Sliwa‐Hähnle²

2019

Topics in Heart Failure Management

View full text Add to dashboard Cite

show abstract

“…The number of persons living with HTN globally is expected to rise to about 1.5 billion by the year 2025 . Sub‐Saharan Africa (SSA) bears a great burden of HTN, which is the leading cause of heart failure and stroke and accounts for over 80% of all cardiovascular disease‐related deaths . In Cameroon, the prevalence of HTN increased over 5‐fold between 1994 and 2003, with a recent community‐based study estimating the prevalence of HTN in the general population at 29.7% .…”

Section: Introductionmentioning

confidence: 99%

Prevalence, awareness, treatment, and control of hypertension in Cameroonians aged 50 years and older: A community‐based study

Tianyi

Agbor²,

Njamnshi

2018

Health Science Reports

Self Cite

View full text Add to dashboard Cite

AimsTo assess the prevalence of hypertension (HTN) in a rural elderly population (50 y and older) in Cameroon; evaluate the rates of awareness, treatment, and control of HTN in this population; and describe factors associated with HTN in this population.Methods and ResultsA total of 501 participants aged 50 years and older were randomly recruited from May to July 2013 in a house‐to‐house survey of the Batibo Health District. Data were measured using standardized methods modelled after the World Health Organization STEPwise approach to Surveillance. The Statistical Package for the Social Sciences version 20.0 was used for statistical analysis. Chi‐square, Fisher's exact or Student T test were used to compare variables. A multivariable logistic regression analysis was used to identify factors associated with HTN in this population. In our study population, 31% of the participants were men, with a mean age of 65.4 ± 8 years; women had a mean age of 61.4 ± 9 years. The prevalence of HTN was 57.3% (95% CI, 52.9‐61.6). The awareness rate was 63.4%, treatment rate 96.7%, and control rate 32.4%. Being overweight/obese was independently associated with HTN in this group (odds ratio = 3.46; 95% CI, 2.38‐5.03; P < .001).ConclusionThe prevalence of HTN amongst the elderly in the Batibo Health District is high. Emphasis should be on patient education to improve the rates of blood pressure control amongst patients on treatment for HTN. Healthy lifestyle measures such as reduction in salt intake and increase in physical exercise should be encouraged amongst the elderly.

show abstract

“…Good adherence is crucial to improve hypertension control rates and prevent complications such as stroke, coronary artery disease, aneurysms, and heart failure . Furthermore, non‐adherence was associated with higher cardiovascular risk …”

Section: Introductionmentioning

confidence: 99%

Adherence to antihypertensive drug treatment in Argentina: A multicenter study

Espeche

Salazar

Sabio³

et al. 2020

J of Clinical Hypertension

View full text Add to dashboard Cite

Adherence to antihypertensive medication is an important challenge that doctors often face in the treatment of hypertension. Good adherence is crucial to prevent cardiovascular complications. In consequence, the present study aimed at determining the prevalence of adherence to antihypertensive treatment and identifying associated clinical variables. A multicenter cross-sectional study was conducted in 12 cities of Argentina.A systematic sampling was performed in order to select patients with hypertension and under pharmacological treatment for at least 6 months. Physicians took three BP measurements, and the level of adherence was assessed using the self-administered Morisky questionnaire (MMAS-8). Participants were classified into three levels of adherence: high adherence-MMAS score of 8; medium adherence-MMAS scores of 6 to <8; and low adherence-MMAS scores of <6. A total of 1111 individuals (62 ± 12 years old, | 657 ESPECHE Et al.

show abstract

Data on the epidemiology of heart failure in Sub-Saharan Africa

Cited by 31 publications

References 31 publications

Heart Failure in Sub-Saharan Africa

Heart Failure in Sub-Saharan Africa

Prevalence, awareness, treatment, and control of hypertension in Cameroonians aged 50 years and older: A community‐based study

Adherence to antihypertensive drug treatment in Argentina: A multicenter study

Contact Info

Product

Resources

About